, Tracking Stock Market Picks
Enter Symbol:
Oncolytics Biotech, Inc. (ONCY) [hlAlert]

down 36.14 %

Oncolytics Biotech, Inc. (ONCY) rated Buy with price target $1.50 by Needham

Posted on: Wednesday,  Mar 18, 2015  8:25 AM ET by Needham

Needham rated Buy Oncolytics Biotech, Inc. (NASDAQ: ONCY) on 03/18/2015. Previously Needham rated Buy Oncolytics Biotech, Inc. (NASDAQ: ONCY) on 09/18/2014.,
when the stock price was $0.83. Since then, Oncolytics Biotech, Inc. has lost 36.14% as of 11/04/2015's recent price of $0.53.
If you would have followed the previous Needham's recommendation on ONCY, you would have lost 36.14% of your investment in 412 days.

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/18/2015 8:25 AM Buy
0.71 1.50
as of 8/27/2015
1 Week down  -5.35 %
1 Month down  -5.35 %
3 Months down  -25.35 %
1 YTD down  -25.35 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/18/2014 8:25 AM Buy
0.83 4.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy